자가혈관내피세포를 도포한 인조혈관의 개발 = Development of Autologous Endothelial Cell Seeded Prosthetic Vascular Graft

다국어 초록 (Multilingual Abstract)

Purpose: Small calibered prosthetic vascular grafts are prone to low patency rates after bypass surgery due to its high thrombogenicity and neointimal hyperplasia. Endothelial cells are known to inhibit thrombus formations, platelet aggregation and smooth muscle cells proliteration. The purpose of this study was to examine the development of autologous endothelial cell seeded prosthetic vascular graft.
Method: The autologous endothelial cells (ECs) were harvested from canine external jugular veins. Approximately 5*10^4 ECs were obtained through passage 5 to 6 under the static condition. The cultured ECs were seeded into the polytetrafluoroethylenc (PTFE) graft and cultured for 3 days before implanting into the canine carotid artery.The PTFE graft was harvested at 6 weeks after implantation.
Result: The primary cultured ECs were treated with Factor VⅢ/WF, CD3]/PECAM-1 antibodyand confirmed with fluorescence micrograph, The gratf patency rates were 2/6 (33%) in the control gratf and 5/6 (83%) in the ECs seeded graft at 6 weeks after implantation. the entire luminal surface of the EC seeded graft was covered with ECs. Only the vicinity of the anastomosis site was covered with ECs in the control graft.
Conclusion: This is a pilot study for the development of autologous endothelial cell seeded prosthetic vascular graft. The results of our study demonstrate that the endothelialized PTFE are better than ninendothelialized PTFE.